Navigation Links
Radiologists identify early brain marker of Alzheimer's disease
Date:9/25/2007

OAK BROOK, Ill. Researchers using functional magnetic resonance imaging (fMRI) have found a new marker which may aid in early diagnosis of Alzheimers disease, according to a study published in the October issue of Radiology.

The findings of this study implicate a potential functional, rather than structural, brain markerseparate from atrophythat may help enhance diagnosis and treatment monitoring of Alzheimers patients, said the studys lead author, Jeffrey R. Petrella, M.D., associate professor of radiology at Duke University Medical Center in Durham, N.C.

Alzheimers disease is a progressive brain disorder characterized by memory loss, confusion, personality or behavioral changes and other symptoms. According to the Alzheimers Association, more than five million Americans currently have Alzheimers disease.

While there is still no cure for the disorder, early diagnosis is crucial so that the patient receives proper treatment.

As new therapies for Alzheimers disease enter the pipeline over the next five years, early diagnosis will become critical for patient selection, Dr. Petrella said. fMRI may play a key role in early diagnosis, when combined with clinical, genetic and other imaging markers.

Among the earliest known changes to the brain in Alzheimers disease are episodic memory deficits and structural changes in the medial temporal lobe (MTL). For the study, Dr. Petrella and colleagues set out to identify brain regions in which changes in activation took place during a memory task and to correlate these changes with the degree of memory impairment present in patients with Alzheimers disease or mild cognitive impairment.

The researchers studied 13 patients with mild Alzheimers disease, 34 patients with mild cognitive impairment and 28 healthy controls. The study group contained 37 men and 38 women with a mean age of 72.9 years. After completing standard neuropsychological testing, the study participants were monitored with fMRI while performing a face-name associative memory task.

While some areas of the brain activate, or turn on their activity, when a person tries to remember something, other areas deactivate, or suppress their activity. Results from this study showed that along the spectrum from healthy people at low risk, to people with mild memory problems, to patients with Alzheimers disease, there was increasingly impaired activation in the MTL, an area of the brain associated with episodic memory that normally turns on during a memory task. More surprising, however, was increasingly impaired deactivation in the posteromedial cortices (PMC), an area recently implicated with personal memory that normally suppresses its activity during a memory task. The magnitude of deactivation in the PMC was closely related to the level of memory impairment in the patients and significantly correlated with their neuropsychological testing scores.

While previous studies have suggested that MTL activation may be a possible marker of Alzheimers, based on the findings, Dr. Petrella and colleagues concluded that, compared to activation in the MTL, deactivation in the PMC may represent a more sensitive marker of early Alzheimers disease.

In other words, the brain not only loses its ability to turn on in certain regions, but also loses its ability to turn off in other regions, and the latter may be a more sensitive marker. These findings give us insight into how the brains memory networks break down, remodel and finally fail as memory impairment ensues, Dr. Petrella said.

The researchers hope that fMRI will eventually help to identify patients at risk for developing Alzheimers disease.

The next step is to conduct a large, multicenter study to see if fMRI can be combined with other imaging and genetic tests to scan for future disease, said study co-author P. Murali Doraiswamy, M.D., chief of the Division of Biological Psychiatry and Alzheimers clinical trial expert at Duke. Much like a negative colonoscopy gives you reassurance, a normal fMRI may, in the future, also offer predictive value.


'/>"/>

Contact: Linda Brooks
media@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Related medicine news :

1. Radiologists Find New CT Scans Useful
2. Technology-enabled diagnosis by overseas radiologists
3. Computer Software Less Reliable Than Radiologists Eyes in Detecting Cancerous Tumors
4. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
5. Now you can identify Sperm and Egg donors
6. Identifying Predictors Of Anthrax
7. Identifying The Risks Of Developing Schizophrenia
8. Researchers identify the early makers of Neonatal Sepsis
9. Researchers Identify Gene Connected To Bipolar Disorder
10. Blood test may identify ovarian cancer
11. Identifying bacteria made amiable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/22/2017)... 2017  As the latest Obamacare repeal effort moves ... (R-LA) and Lindsey Graham (R-SC) medical ... device industry is in an odd place.  The industry ... excise tax on medical device sales passed along with ... patients, increased visits and hospital customers with the funding ...
Breaking Medicine Technology: